Price Alert

Cartesian Therapeutics In... (RNAC)

NASDAQ: RNAC · Real-Time Price · USD

11.33

-0.10 (-0.87%)

At close: Aug 15, 2025, 3:59 PM

-0.87% (1D)

Bid	11.15
Market Cap	294.6M
Revenue (ttm)	1.03M
Net Income (ttm)	-36.26M
EPS (ttm)	-0.68
PE Ratio (ttm)	-16.66
Forward PE	-2.81
Analyst	Buy

Ask	11.8
Volume	47,939
Avg. Volume (20D)	66,930
Open	11.29
Previous Close	11.43
Day's Range	11.04 - 11.79
52-Week Range	8.46 - 26.50
Beta	0.43

About RNAC

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol RNAC

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for RNAC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Cartesian Therapeutics has released their quartely earnings on Aug 7, 2025:

Revenue of $298K misses estimates by $489.5K, with -99.11% YoY decline.

EPS of 0.5 exceeds estimates by 1.19, with -7.41% YoY decline.

Next Earnings Release

Cartesian Therapeutics Inc. is scheduled to release its earnings on Nov 6, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 month ago

+21.86%

Cartesian Therapeutics shares are trading higher a... Unlock content with Pro Subscription

News

1 week ago · fool.com

Cartesian (RNAC) Q2 Revenue Drops 99%

3 weeks ago · zacks.com

Cartesian Therapeutics, Inc. (RNAC) Moves 9.9% Higher: Will This Strength Last?

Cartesian Therapeutics, Inc. (RNAC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further...